Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Highlights,Commonwealth Equity Services LLC refines its position in Viking Therapeutics Inc.,Company operates within the ...

Explore the critical differences in how women's pain is processed and how tailored treatments can alleviate chronic pain.

Latigo Biotherapeutics, Vivace Therapeutics, and Vori Health each announced the recent successful closing of their respective ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Heron ...

THOUSAND OAKS, Calif., March 17, 2025 /PRNewswire/ -- Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments that target pain ...

ATLANTA - Dogwood Therapeutics, Inc. (NASDAQ:DWTX), a biopharmaceutical company specializing in non-opioid pain treatments, has announced the initiation of a Phase 2b clinical trial for Halneuron ...

Dogwood Therapeutics, Inc. has announced the dosing ... which studies Halneuron® as a treatment for chemotherapy-induced neuropathic pain. Halneuron® is designed to target the NaV 1.7 sodium ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for ...